<DOC>
	<DOC>NCT03095521</DOC>
	<brief_summary>The purpose of this study is to evaluate no less therapeutic efficacy and safety of the Angal, lozenges [Menthol], 1 mg + 5 mg (Sandoz dd, Slovenia) compared to ANTI-ANGIN® FORMULA, lozenges, 0,2 mg + 2 mg + 50 mg (LLC "Valeant", Russia) in treatment of patients with uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat.</brief_summary>
	<brief_title>A Local Clinical Study for the Comparative Evaluation of Efficacy and Safety of Angal, Lozenges [Menthol] and ANTI-ANGIN® FORMULA, Lozenges, in Treatment of Patients With a Sore Throat</brief_title>
	<detailed_description />
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Voluntarily signed informed consent for participation in this clinical study; 18 to 45 years old inclusive, male and female; Diagnosed uncomplicated acute infectious and inflammatory diseases of the pharynx, accompanied by a sore throat; Onset of first symptoms of the uncomplicated acute infectious and inflammatory diseases of the pharynx (pharyngitis and/or tonsillitis) less than 48 hours prior to inclusion into the study; Baseline TSS score (Tonsillopharyngitis Severity Score) ≥ 5 (total score); Use of analgesics within &lt;12 hours prior to the study start or/and inability to cancel them during the study; Use of antibiotics within &lt;48 hours prior to the study start or/and inability to cancel them during the study; Use of local therapy (sprays, rinses, lozenges) to pharynx within &lt;12 hours before study start or/and inability to cancel them, besides study medications. Use systemic or inhaled corticosteroids within ≤1 months prior to the study start and planned therapy of them during the study (besides skin means). Presence of symptoms of primary bacterial pharyngitis or secondary bacterial infection (including fever over 37,5 ° C, the presence of purulent raids in the throat, severe intoxication, leukocytosis, neutrophilia, shift leukocyte left (increasing the percentage of neutrophils sticks appearance younger forms of neutrophils), increased ESR 30 mm/hr);</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Angal</keyword>
	<keyword>ANTI-ANGIN® FORMULA</keyword>
	<keyword>sore throat</keyword>
	<keyword>no less therapeutic efficacy</keyword>
</DOC>